Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 252

1.

Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract.

Pelley RJ, Bukowski RM.

Curr Opin Oncol. 1997 Jan;9(1):68-74. Review.

PMID:
9090496
[PubMed - indexed for MEDLINE]
2.

Recent advances in systemic therapy for gastrointestinal neuroendocrine tumors.

Pelley RJ, Bukowski RM.

Curr Opin Oncol. 1999 Jan;11(1):32-7. Review.

PMID:
9914875
[PubMed - indexed for MEDLINE]
3.

The visualization of gastroenteropancreatic endocrine tumors.

Lamberts SW, Chayvialle JA, Krenning EP.

Digestion. 1993;54 Suppl 1:92-7. Review.

PMID:
8395433
[PubMed - indexed for MEDLINE]
4.

[Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].

Banzo J, Abós MD, Prats E, García F, Razola P.

Rev Esp Med Nucl. 2000 Jun;19(3):225-41. Review. Spanish. No abstract available.

PMID:
11062088
[PubMed - indexed for MEDLINE]
5.

[Neuroendocrine tumors of the gastrointestinal tract].

Arnold C.

Praxis (Bern 1994). 2007 Jan 10;96(1-2):19-28. Review. German.

PMID:
17256557
[PubMed - indexed for MEDLINE]
6.

Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction.

Wängberg B, Westberg G, Tylén U, Tisell L, Jansson S, Nilsson O, Johansson V, Scherstén T, Ahlman H.

World J Surg. 1996 Sep;20(7):892-9; discussion 899.

PMID:
8678968
[PubMed - indexed for MEDLINE]
7.

Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.

Wiedenmann B, Bäder HM, Scherubl H, Fett U, Zimmer T, Hamm B, Koppenhagen K, Riecken EO.

Semin Oncol. 1994 Oct;21(5 Suppl 13):29-32. No abstract available.

PMID:
7992077
[PubMed - indexed for MEDLINE]
8.

[Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].

Weinel RJ, Kisker O, Joseph K, Welcke U, Zaraca F, Rothmund M.

Chirurg. 1994 Oct;65(10):849-55. German.

PMID:
7821043
[PubMed - indexed for MEDLINE]
9.

64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.

Anderson CJ, Dehdashti F, Cutler PD, Schwarz SW, Laforest R, Bass LA, Lewis JS, McCarthy DW.

J Nucl Med. 2001 Feb;42(2):213-21.

PMID:
11216519
[PubMed - indexed for MEDLINE]
Free Article
10.

Localization of gastroenteropancreatic neuroendocrine tumors with 111indium-pentetreotide scintigraphy.

Pauwels S, Leners N, Fiasse R, Jamar F.

Semin Oncol. 1994 Oct;21(5 Suppl 13):15-20. No abstract available.

PMID:
7992075
[PubMed - indexed for MEDLINE]
11.

Metastatic neuroendocrine hepatic tumors: resection improves survival.

Musunuru S, Chen H, Rajpal S, Stephani N, McDermott JC, Holen K, Rikkers LF, Weber SM.

Arch Surg. 2006 Oct;141(10):1000-4; discussion 1005.

PMID:
17043278
[PubMed - indexed for MEDLINE]
12.

Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.

Nikou GC, Lygidakis NJ, Toubanakis C, Pavlatos S, Tseleni-Balafouta S, Giannatou E, Mallas E, Safioleas M.

Hepatogastroenterology. 2005 May-Jun;52(63):731-41.

PMID:
15966194
[PubMed - indexed for MEDLINE]
13.

Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.

Strosberg JR, Choi J, Cantor AB, Kvols LK.

Cancer Control. 2006 Jan;13(1):72-8.

PMID:
16508629
[PubMed - indexed for MEDLINE]
Free Article
14.

[Medical treatment of digestive neuroendocrine tumours].

Panzuto F, Nasoni S, Delle Fave G.

Minerva Endocrinol. 2001 Sep;26(3):145-8. Review. Italian.

PMID:
11753237
[PubMed - indexed for MEDLINE]
15.

Experience with indium-111 and yttrium-90-labeled somatostatin analogs.

Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Burggasser G, Andreae F, Kurtaran A, Dudczak R.

Curr Pharm Des. 2002;8(20):1781-807. Review.

PMID:
12171531
[PubMed - indexed for MEDLINE]
16.

Advances in the treatment of neuroendocrine tumors.

Kulke M.

Curr Treat Options Oncol. 2005 Sep;6(5):397-409. Review.

PMID:
16107243
[PubMed - indexed for MEDLINE]
17.

Biology, diagnosis, and treatment of neuroendocrine tumors of the gastrointestinal tract.

Oberg K.

Curr Opin Oncol. 1994 Jul;6(4):441-51. Review.

PMID:
7803546
[PubMed - indexed for MEDLINE]
18.

Multimodality treatment for gastric carcinoid tumor with liver metastases.

Caplin ME, Hodgson HJ, Dhillon AP, Begent R, Buscombe J, Dick R, Rolles K, Burroughs AK.

Am J Gastroenterol. 1998 Oct;93(10):1945-8.

PMID:
9772061
[PubMed - indexed for MEDLINE]
19.

Hepatic artery embolization for metastatic endocrine-secreting tumors of the pancreas. Report of two cases.

Clouse ME, Lee RG, Duszlak EJ, Lokich JJ, Alday MT.

Gastroenterology. 1983 Nov;85(5):1183-6.

PMID:
6194040
[PubMed - indexed for MEDLINE]
20.

Recent advances in carcinoids and gastrointestinal neuroendocrine tumors.

Basser RL, Green MD.

Curr Opin Oncol. 1991 Feb;3(1):109-20. Review.

PMID:
2043691
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk